Cargando…
Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
To outline further genetic mechanisms of transformation from follicular lymphoma (FL) to diffuse large B-cell lymphoma (DLBCL), we have performed whole genome array-CGH in 81 tumors from 60 patients [29 de novo DLBCL (dnDLBCL), 31 transformed DLBCL (tDLBCL), and 21 antecedent FL]. In 15 patients, pa...
Autores principales: | Kwiecinska, Anna, Ichimura, Koichi, Berglund, Mattias, Dinets, Andrii, Sulaiman, Luqman, Collins, V Peter, Larsson, Catharina, Porwit, Anna, Lagercrantz, Svetlana Bajalica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369132/ https://www.ncbi.nlm.nih.gov/pubmed/24832791 http://dx.doi.org/10.1002/gcc.22184 |
Ejemplares similares
-
Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies
por: Altena, Renske, et al.
Publicado: (2022) -
Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2021) -
Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2022) -
Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020) -
Reply to Kratz et al.
por: Frebourg, Thierry, et al.
Publicado: (2020)